Science 37 Holdings, Inc. (SNCE)

Overview

Science 37 Holdings, Inc. specializes in pioneering technology solutions that enable flexible and decentralized clinical trials. Through their central platform, they offer modern, digital methodologies for conducting clinical research by uniting all essential stakeholders, including patients, trial investigators, nurses, coordinators, and sponsors. This collaborative approach streamlines processes, centralizes data generation, and ensures the standardization of information across all parties. The integration of specialized networks encompasses patient communities, telemedicine-enabled investigators, mobile nursing professionals, remote coordinators, and connected health devices, all of which are crucial for managing adaptable clinical studies. The platform's highly configurable nature allows it to support virtually any phase of a clinical study, catering to a vast array of medical indications. Additionally, the company licenses its proprietary, cloud-based technology platform to a variety of life science institutions. Established in 2014 and headquartered in Research Triangle Park, North Carolina, Science 37 serves a diverse client base, including prominent pharmaceutical companies, mid-sized firms, Contract Research Organizations (CROs), academic institutions, and biotechnology companies.

Products and Services

• Decentralized Clinical Trials:

  Science 37 offers solutions that allow clinical trials to be conducted remotely, making them more accessible to patients. This flexibility enhances patient recruitment and retention while reducing logistical challenges typically associated with traditional trial methodologies.

• Technology Platform:

  The company's cloud-based platform centralizes data management and streamlines processes, ensuring that all stakeholders have access to consistent and standardized information necessary for informed decision-making throughout the trial lifecycle.

• Telemedicine Integration:

  Utilizing telemedicine technology, Science 37 enables investigators to engage with patients remotely, facilitating consultations, follow-ups, and monitoring. This increases patient engagement and allows for quicker access to essential health data.

• Mobile Nursing Services:

  The integration of mobile nursing professionals allows for on-site visits and assessments, enhancing patient convenience and adherence to trial protocols while providing additional layers of clinical support.

• Patient-Centric Recruitment Platforms:

  By connecting with specialized networks of patient communities, Science 37 enhances recruitment strategies, making it easier to reach and recruit diverse and representative patient populations tailored to specific study requirements.

• Licensing of Proprietary Technology:

  Science 37 licenses its innovative technology to other life science institutions, allowing them to leverage the strengths of its platform in their own clinical trial operations, enhancing overall efficiency and effectiveness.